Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)
07:00am, Thursday, 07'th Aug 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
Curious about Insulet (PODD) Q2 Performance? Explore Wall Street Estimates for Key Metrics
10:16am, Tuesday, 05'th Aug 2025
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Insulet (PODD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:50am, Tuesday, 05'th Aug 2025
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth
11:08am, Thursday, 31'st Jul 2025
Insulet (PODD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Wednesday, 09'th Jul 2025
Insulet (PODD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025
06:00am, Tuesday, 08'th Jul 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids
12:20pm, Tuesday, 01'st Jul 2025
Shares of Dexcom, Tandem Diabetes and Insulet skidded Tuesday on a proposal that would cut Medicare reimbursements for wearable diabetes tech.
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
09:10am, Saturday, 28'th Jun 2025
There's a strong case that healthcare is the most important sector in the stock market. These companies deliver innovative therapies and medical technologies that are often life-saving.
ACTON, Mass.--(BUSINESS WIRE)--Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod 5 on Improved Health Outcomes at the American Diabetes Association Conference.
Here's Why You Should Retain PODD Stock in Your Portfolio Now
10:56am, Wednesday, 11'th Jun 2025
Insulet's Omnipod 5 gains traction with global expansion and rising Type 2 adoption despite economic and competitive hurdles.
Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users
08:30am, Tuesday, 10'th Jun 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod® 5 App for iPhone is now compatible w
3 Medical Technology Stocks Outperforming in 2025
07:29am, Monday, 09'th Jun 2025
As the broader market stages a sharp rebound from its April lows, several sectors, industries, and stocks have quietly emerged as leaders. Among them, the medical technology industry, known for its in
Here's Why Insulet (PODD) is a Strong Growth Stock
10:51am, Wednesday, 04'th Jun 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
S&P 500 Wraps Up Best May Since 1990: 5 Top Stocks in the ETF
12:31pm, Tuesday, 03'rd Jun 2025
SPY jumped 6.3% in May, the most in decades, led by standout gains in NRG, STX, CEG, PODD and MCHP amid easing trade fears.
Insulet Gains 78.5% in a Year: What's Driving the Stock?
09:31am, Monday, 26'th May 2025
PODD's shares rise on the back of Omnipod 5's growth, global expansion, and strong Q1 2025 gains despite rising operating costs and macro headwinds.
